Quantcast

Latest hypernatremia Stories

Peer Pressure And Soy Sauce Overdose Puts Teen Into Coma
2013-06-09 08:19:03

redOrbit Staff & Wire Reports — Your Universe Online It was almost “death by condiment” for a 19-year-old man, who very nearly lost his life after consuming more than a quart of soy sauce on a dare, various media outlets reported over the weekend. The unnamed teenager, who was the subject of a case study in the Journal of Emergency Medicine, slipped into a coma with seizure-like activity after overdosing on the sodium-heavy substance. He was rushed to the...

2010-09-22 13:49:18

Hyponatremia may lead to neurological complications A new study published in the October issue of the journal Hepatology found that patients with severe portal-hypertensive bleeding who are treated with terlipressin may experience an acute reduction of sodium in their blood. This reduction in serum sodium, known as hyponatremia, can cause adverse reactions such as neurological complications, and is rapidly reversible upon terlipressin withdrawal. Researchers suggest that serum sodium should...

2009-05-21 12:51:00

Once-Daily SAMSCA Increases Serum Sodium Levels Through Increase in Free Water Clearance TOKYO and PRINCETON, N.J., May 21 /PRNewswire/ -- Otsuka Pharmaceutical Co., Ltd. (OPC) and Otsuka Pharmaceutical Development and Commercialization, Inc. (OPDC) announced today that the U.S. Food and Drug Administration (FDA) has approved SAMSCA(TM) (tolvaptan) as the only oral selective vasopressin antagonist for the treatment of patients with clinically significant hypervolemic and euvolemic...

2009-04-01 09:00:00

Arginine vasopressin (AVP) receptor antagonist now available in new premixed formulation DEERFIELD, Ill., April 1 /PRNewswire/ -- Astellas Pharma US, Inc. today announced the commercial availability of Vaprisol(R) (conivaptan hydrochloride injection) Premixed in 5% Dextrose, a new premixed formulation. Discovered and developed by Astellas, Vaprisol, an arginine vasopressin (AVP) receptor antagonist, is the first and only approved drug indicated for the treatment of both euvolemic and...

2008-10-22 12:00:16

DEERFIELD, Ill., Oct. 22 /PRNewswire/ -- Astellas Pharma US, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a new premixed formulation of Vaprisol: Vaprisol(R) (conivaptan hydrochloride injection) Premixed in 5% Dextrose. Discovered and developed by Astellas, Vaprisol, an arginine vasopressin (AVP) receptor antagonist, is the first and only approved drug indicated for the treatment of both euvolemic and hypervolemic hyponatremia in hospitalized patients....

2007-07-04 18:19:37

By Uras, Nurdan Karadag, Ahmet; Dogan, Guzide; Tonbul, Alparslan; Tatli, M Mansur Abstract Objectives. This study was carried out to assess the incidence, presenting complaints, risk factors, and methods for prevention of hypematremic dehydration among term and near-term breastfeeding infants. Methods. We retrospectively evaluated term and near-term (>/=35 weeks of gestation) neonates admitted to our neonatology department, during a four-year period with serum sodium concentrations of...


Word of the Day
pungle
  • To take pains; labor assiduously with little progress.
This word comes from the Spanish 'pongale,' put it.
Related